Related Experiment Video
Updated: Feb 4, 2026
Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
Published on: May 1, 2019
Gastric cancer: Basic aspects
Henrique O Duarte1,2,3, Joana Gomes1,2, José C Machado1,2,4
1i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Abstract:
Despite major breakthroughs in the field of personalized medicine, gastric cancer (GC) remains a clinically challenging disease, characterized by scarce effective treatment options and the lack of reliable molecular tools for the prediction of patient outcome and response to therapy. The pronounced molecular heterogeneity that dictates the phenotypical aggressiveness of gastric neoplasms severely limits the antitumor efficacy of targeted agents brought to clinical trials, and constitutes a favorable setting for the emergence of refractory tumors exhibiting multidrug resistance. We will review the most recent advances in our understanding of GC biology, which are underlying the development and clinical testing of novel targeted therapeutic agents. We will also emphasize how their efficacy and acquired resistance relate to the aberrant molecular signatures that drive gastric malignancy.
Insights
Gastric cancer (GC) presents treatment challenges due to molecular heterogeneity. Understanding GC biology and molecular signatures is key to developing effective targeted therapies and overcoming drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Personalized Medicine
Background:
- Gastric cancer (GC) remains a significant clinical challenge despite advances in personalized medicine.
- Limited effective treatments and predictive molecular tools hinder patient outcome and therapy response assessment.
- Tumor molecular heterogeneity drives aggressiveness, limits targeted therapy efficacy, and promotes multidrug resistance.
Purpose of the Study:
- To review recent advances in gastric cancer (GC) biology.
- To discuss the development and clinical testing of novel targeted therapeutic agents for GC.
- To emphasize the relationship between molecular signatures, targeted agent efficacy, and acquired resistance in GC.
Main Methods:
- Literature review of recent scientific publications on gastric cancer biology.
- Analysis of current clinical trials for novel targeted therapies in GC.
- Examination of molecular signatures driving GC and their impact on treatment response.
Main Results:
- Recent research has elucidated key molecular mechanisms underlying GC.
- Novel targeted therapeutic agents are under development and clinical evaluation for GC.
- Aberrant molecular signatures in GC are closely linked to both treatment efficacy and the development of resistance.
Conclusions:
- Advances in understanding GC biology are paving the way for new targeted therapies.
- Addressing molecular heterogeneity and resistance mechanisms is crucial for improving GC treatment outcomes.
- Personalized medicine approaches targeting specific molecular signatures hold promise for future GC management.
Related Concept Videos
02:27Energy Basics
01:16Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
01:16Gastric Emptying
01:21Basicity of Aliphatic Amines
To measure the basicity of amines, two conventions are generally used. The first defines Kb as the basicity constant for the deprotonation reaction of water by the amine, as presented in Figure 1. Conventionally, lower Kb indicates higher...
01:22Basic Operations on Signals
Time Reversal mirrors a continuous-time signal about the vertical axis at t=0. This is achieved by substituting t with −t. For example, if a signal x(t) is considered, the time-reversed signal is x(−t). This operation can be graphically represented, showing the mirrored signal.
01:26Gastric Phase of Digestion
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...